A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients With Generalized Myasthenia Gravis

This Study is
No Longer Enrolling

Details
Age

Adult

Type of Study

Treatment

Locations

Outpatient CTRC
University of Colorado Hospital

Study ID

Protocol Number: 20-0609

More information available at ClinicalTrials.gov: NCT04159805

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers